Adriana Tajonar Ph.D Overview

  • Primary Position
  • Board Observer

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 1

  • Med. Deal Size

  • Med. Valuation

Adriana Tajonar Ph.D General Information

Biography

Dr. Adriana Tajonar serves as Board Observer at Nested Therapeutics. She served as a Principal at The Column Group. She was a Board Member at Carmot Therapeutics. She joined The Column Group in 2015. Previously, She was an Entrepreneurship Program Manager at QB3 (California Institute for Quantitative Biosciences), where she helped over 200 teams of scientists from top institutions in California start companies in the life sciences. Prior to QB3, she studied mechanisms of self-renewal and survival in human embryonic stem cells in the laboratory of Professor Douglas Melton, completing her PhD at Harvard University in 2012. Previously, she did research in the lab of Professor Rudolf Jaenisch as an undergraduate at the Massachusetts Institute of Technology. She served as Board Member at A2 Biotherapeutics.

Contact Information

Primary Position
Board Observer, Nested Therapeutics
Education
Harvard University, Ph.D. (Doctor of Philosophy)
Massachusetts Institute of Technology (MIT), BS (Bachelor of Science)
Gender
Female
Phone
+1 (415)
Address
  • 1030 Massachusetts Avenue
  • Suite 410
  • Cambridge, MA 02138
  • United States

Adriana Tajonar Ph.D Board Seats (1)

Company Industry Ownership Status Financing Status Location Since
Nested Therapeutics Drug Discovery Privately Held (backing) Venture Capital-Backed Cambridge, MA

Adriana Tajonar Ph.D Lead Partner on Deals (2)

Adriana Tajonar Ph.D has been the lead partner on 2 deals. Their latest deal was with A2 Bio, a biotechnology company. The deal was made for on 05-Nov-2019.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
A2 Bio 05-Nov-2019 Early Stage VC (Series A) Completed Biotechnology Agoura Hills, CA
Carmot Therapeutics 17-Jan-2018 Completed Biotechnology Berkeley, CA

Adriana Tajonar Ph.D Network (59)

Board Members (30)

Name Company Representing Location From
Timothy Kutzkey Ph.D Carmot Therapeutics The Column Group Berkeley, CA
Michael Gallo Ph.D A2 Bio Self Agoura Hills, CA
Nested Therapeutics Nested Therapeutics Cambridge, MA
Carmot Therapeutics Carmot Therapeutics Berkeley, CA
A2 Bio Self Agoura Hills, CA

Portfolio Executives (21)

Name Company Role Deal date Location
Michael Gallo Ph.D A2 Bio Co-Founder & Board Member 05-Nov-2019 Agoura Hills, CA
Alexander Kamb Ph.D A2 Bio Co-Founder, Chief Scientific Officer & Board Member 05-Nov-2019 Agoura Hills, CA
A2 Bio Co-Founder 05-Nov-2019 Agoura Hills, CA
A2 Bio Chief Business Officer 05-Nov-2019 Agoura Hills, CA
A2 Bio Chief Operating Officer 05-Nov-2019 Agoura Hills, CA

Fund Team Members (8)

Name Investor Fund Fund Location
Timothy Kutzkey Ph.D The Column Group Column Group II San Francisco, CA
Timothy Kutzkey Ph.D The Column Group Column Group III San Francisco, CA
The Column Group San Francisco, CA
The Column Group San Francisco, CA
The Column Group San Francisco, CA

Adriana Tajonar Ph.D Affiliated Funds (3)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
Column Group II The Column Group Venture - General Closed 2014
Column Group III The Column Group Venture - General Closed 2016
The Column Group Fund The Column Group Hedge Fund Liquidated

Adriana Tajonar Ph.D FAQs

  • Who is Adriana Tajonar Ph.D?

    Dr. Adriana Tajonar serves as Board Observer at Nested Therapeutics.

  • How much does Adriana Tajonar Ph.D typically invest?

    Adriana Tajonar Ph.D's median deal size is .

  • What is Adriana Tajonar Ph.D’s main position?

    Adriana Tajonar Ph.D’s primary position is Board Observer.

  • How many active board seats does Adriana Tajonar Ph.D hold?

    Adriana Tajonar Ph.D holds a board seat in Nested Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »